ImageneBio (IMA) Total Current Liabilities (2020 - 2025)

ImageneBio has disclosed Total Current Liabilities across 6 years of filings, most recently posting $11.2 million for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $11.2 million, down 34.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.2 million (down 34.72% YoY), and the FY2025 annual result was $11.2 million, down 34.72% from the prior year.
• Total Current Liabilities came in at $11.2 million for Q4 2025 at ImageneBio, up from $11.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $30.6 million in Q3 2021 to a low of $7.3 million in Q2 2025.
• The 5-year median for Total Current Liabilities is $15.7 million (2023), against an average of $18.1 million.
• Across the five-year window, Total Current Liabilities sank 57.89% in 2023 and rose 21.15% in 2024, its largest moves.
• ImageneBio's Total Current Liabilities stood at $27.2 million in 2021, then dropped by 20.91% to $21.5 million in 2022, then slumped by 33.94% to $14.2 million in 2023, then climbed by 21.15% to $17.2 million in 2024, then sank by 34.72% to $11.2 million in 2025.
• The last three Total Current Liabilities figures came in at $11.2 million (Q4 2025), $11.1 million (Q3 2025), and $7.3 million (Q2 2025), per Business Quant data.